Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>Azitra is developing genetically engineered bacteria for therapeutic use in dermatology.</li><li>The company possesses a microbial library of 1,500 unique bacterial strains that are candidates for a variety of indications.</li><li>Azitra's lead candidate is ATR-12 for the rare disease Netherton syndrome (NS).</li></ul>

Azitra is developing genetically engineered bacteria for therapeutic use in dermatology.The company possesses a microbial library of 1,500 unique bacterial strains that are candidates for a variety of indications.Azitra's lead candidate is ATR-12 for the rare disease Netherton syndrome (NS).

AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025